Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.96 2.59 −1.48%
Market cap
$49.5B
P/E
34.0×
Fwd P/E
26.3×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100
Jul '26 Apr '26 Jan '26 Oct '25 Older periods
Piotroski F-Score
7 7 5 5

+8 more TTM periods

ROE
20.97% 21.33% 19.95% 20.62%
ROA
11.00% 11.21% 10.43% 10.61%
ROIC
11.07% 11.62% 11.10% 11.55%
Return on Tangible Assets
31.73% 30.79% 28.93% 30.52%
Average Days of Receivables
73.18 75.60 78.58 78.12
Free Cash Flow per Share
4.49 3.85 3.51 4.06
Free Cash Flow
1,267.00 1,087.00 993.00 1,152.00
Capital Expenditures
(342.00) (365.00) (403.00) (407.00)
Other line items
Cash ROIC
9.92% 9.07% 8.48% 9.95%
Accounts Receivable Turnover
5.16 5.05 4.96 4.94
Accounts Payable Turnover
5.98 6.04 5.87 5.96
Inventory Turnover
3.19 3.29 3.28 3.31
Average Days of Payables
65.19 65.67 65.11 62.95
Days of Inventory on Hand
119.77 116.29 114.53 113.20
Tax Rate
(0.13) (0.11) (0.10) (0.09)
Research and Development Expense of Revenue
6.58% 6.54% 6.50% 6.55%
Selling, General and Administrative Expense of Revenue
25.01% 24.70% 25.12% 24.60%
Share Based Compensation of Revenue
1.78% 1.81% 1.83% 1.84%
Interest Coverage
15.46 14.81 13.36 13.21
Operating CF/Net income
1.12 1.03 1.08 1.20
Depreciation/Fixed assets
0.13 0.13 0.14 0.14
Capex/Depreciation
(1.26) (1.32) (1.42) (1.41)
Revenue per Share
26.14 25.65 24.96 24.46
Operating CF per Share
5.71 5.15 4.93 5.49
Capex per Share
(1.21) (1.29) (1.42) (1.43)
Capex to Sales
0.05 0.05 0.06 0.06

Fold the line items

Columns are period end dates